Release Date: 28/09/10 09:42 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 13.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%